cells Article WNT5a-ROR Signaling Is Essential for Alveologenesis Changgong Li 1,* , Susan M Smith 1, Neil Peinado 1, Feng Gao 1, Wei Li 1, Matt K Lee 1, Beiyun Zhou 2, Saverio Bellusci 1,3 , Gloria S Pryhuber 4, Hsin-Yi Henry Ho 5 , Zea Borok 2 and Parviz Minoo 1,* 1 Division of Neonatology, Departments of Pediatrics, LAC+USC Medical Center and Childrens Hospital, Los Angeles, CA 90033, USA;
[email protected] (S.M.S.);
[email protected] (N.P.);
[email protected] (F.G.);
[email protected] (W.L.);
[email protected] (M.K.L.);
[email protected] (S.B.) 2 Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Keck School of Medicine of USC, Los Angeles, CA 90033, USA;
[email protected] (B.Z.);
[email protected] (Z.B.) 3 Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen 35390, Germany 4 Division of Neonatology, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY 14642, USA;
[email protected] 5 Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis, CA 95616, USA;
[email protected] * Correspondence:
[email protected] (C.L.);
[email protected] (P.M.); Tel.: 3234420383 (C.L.); 3234093406 (P.M.) Received: 20 December 2019; Accepted: 6 February 2020; Published: 7 February 2020 Abstract: WNT5a is a mainly “non-canonical” WNT ligand whose dysregulation is observed in lung diseases such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and asthma.